文献速递肿瘤 PET/CT

68Ga-FAPI-04 PET/CT在嫌色细胞肾细胞癌再分期中显示软组织及肝转移灶的优势

Superiority of 68Ga-FAPI-04 in Delineation of Soft Tissue and Liver Metastases in Chromophobe Renal Cell Carcinoma for Restaging.
PubMed 文献 · Clin Nucl Med · 2022-08-12

本文报道一例56岁女性转移性嫌色细胞肾细胞癌患者,比较18F-FDG PET/CT与68Ga-FAPI-04 PET/CT表现。68Ga-FAPI-04 PET/CT显示肝、左后腹壁及左腰部转移灶摄取强烈,高于18F-FDG PET/CT,且病灶勾勒更清晰;作者认为68Ga-FAPI-04 PET/CT在嫌色细胞肾细胞癌再分期中可能具有前景。

要点

  • 56岁女性嫌色细胞肾细胞癌转移患者,肝、左后腹壁及左腰部转移灶68Ga-FAPI-04摄取高于18F-FDG。
  • 68Ga-FAPI-04 PET/CT对转移灶的勾勒较18F-FDG PET/CT更清晰。
  • 作者认为68Ga-FAPI-04 PET/CT在嫌色细胞肾细胞癌再分期中可能具有前景。

核心结论

  • 作者认为68Ga-FAPI-04 PET/CT在嫌色细胞肾细胞癌再分期中可能具有前景。

研究设计与样本

  • 单例病例报告:56岁女性转移性嫌色细胞肾细胞癌患者,行18F-FDG PET/CT与68Ga-FAPI-04 PET/CT检查。

主要发现

  • 68Ga-FAPI-04 PET/CT显示肝、左后腹壁及左腰部转移灶摄取强烈,高于18F-FDG PET/CT上的18F-FDG摄取。
  • 68Ga-FAPI-04 PET/CT对转移灶的勾勒较18F-FDG PET/CT更清晰。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chromophobe renal cell carcinoma (RCC) is a rare tumor. We described findings of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT of metastatic chromophobe RCC in a 56-year-old woman. 68Ga-FAPI-04 PET/CT demonstrated that the metastatic lesions in the liver, left posterior abdominal wall, and the left waist had intense uptake of 68Ga-FAPI-04, which was higher than that of 18F-FDG on 18F-FDG PET/CT. 68Ga-FAPI-04 PET/CT also delineated the metastatic lesions more clearly than 18F-FDG PET/CT. This case highlights 68Ga-FAPI-04 PET/CT may be promising in restaging of chromophobe RCC.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Xie F, Fu L, Zhou W, et al. Superiority of 68Ga-FAPI-04 in Delineation of Soft Tissue and Liver Metastases in Chromophobe Renal Cell Carcinoma for Restaging. Clin Nucl Med. 2022. PMID: 36342807. doi:10.1097/RLU.0000000000004374

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。